Abstract
Valproate is one of the most used anti-epileptic drugs. Its common side effects are nausea, vomiting, weight gain, hair loss, tremor, changes in behavior, slowed thinking and impaired liver function. Blood dyscrasias are also relatively frequent and a few studies reported changes in serum immunoglobulin concentrations with valproate treatment. We describe a case of panhypogammaglobulinemia with transient pancytopenia due to valproate. Pancytopenia was recovered after discontinuation of valproate but panhypogammaglobulinemia has been persisting. Intravenous immunoglobulin is being administrated monthly. Previous reports describe that other sodium channel blockers, such as phenytoin and carbamazepine, have been associated with hypogammaglobulinemia. This report also suggests that immunodeficiencies can be caused by valproate.
References
Callenbach PM, Jol-Van Der Zijde CM, Geerts AT et al (2003) Immunoglobulins in children with epilepsy: the Dutch Study of Epilepsy in Childhood. Clin Exp Immunol 132:144–151
Travin M, Macris NT, Block JM et al (1989) Reversible common variable immunodeficiency syndrome induced by phenytoin. Arch Intern Med 149:1421–1422
Ranua J, Luoma K, Auvinen A et al (2005) Serum IgA, IgG, and IgM concentrations in patients with epilepsy and matched controls: a cohort-based cross-sectional study. Epilepsy Behav 6:191–195
Ozaras N, Goksugur N, Eroglu S et al (2012) Carbamazepine-induced hypogammaglobulinemia. Seizure 21:229–231
Smith J, Fernando T, McGrath N et al (2004) Lamotrigine-induced common variable immune deficiency. Neurology 62:833–834
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eom, TH., Lee, HS., Jang, PS. et al. Valproate-induced panhypogammaglobulinemia. Neurol Sci 34, 1003–1004 (2013). https://doi.org/10.1007/s10072-012-1153-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-012-1153-3